Patents by Inventor Barry Teobald

Barry Teobald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUINUCLIDINOL DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS
    Publication number: 20100113510
    Abstract: The invention provides compounds of formula (I) wherein R5 is a group of formula (II) or (III) and R1, R2, R3, R4, R6, a, b, Z, Y and X are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them, a process for preparing pharmaceutical compositions, their use in therapy and intermediates of use in their preparation.
    Type: Application
    Filed: December 17, 2007
    Publication date: May 6, 2010
    Inventors: Rhonan Ford, Antonio Mete, Ian Millichip, Barry Teobald
  • Sulptionamide compounds that modulate chemokine receptor activity (CCR4)
    Publication number: 20060128723
    Abstract: The invention provides thienylsulphonamides for use in therapy.
    Type: Application
    Filed: June 2, 2004
    Publication date: June 15, 2006
    Inventors: Antonio Mete, Barry Teobald
  • Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
    Publication number: 20060122195
    Abstract: The invention relates to sulphonamide compounds, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: June 2, 2004
    Publication date: June 8, 2006
    Inventors: Richard Harrison, Antonio Mete, Barry Teobald, Iain Walters
  • Novel compounds
    Publication number: 20040214864
    Abstract: The invention provides certain 1,2,4-triazole-3-thione compounds, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: October 3, 2002
    Publication date: October 28, 2004
    Inventors: Peter Cage, Barry Teobald
  • Triazolo[4,5-d]pyrimidinyl compounds
    Patent number: 6767910
    Abstract: Compounds of the formula (I) and their use as anti-platelet aggregation compounds.
    Type: Grant
    Filed: September 3, 2002
    Date of Patent: July 27, 2004
    Assignee: AstraZeneca AB
    Inventor: Barry Teobald